Found: 1
Select item for more details and to access through your institution.
Adjunctive interleukin-2 for the treatment of drug-susceptible tuberculosis: a randomized control trial in China.
- Published in:
- Infection, 2022, v. 50, n. 2, p. 413, doi. 10.1007/s15010-021-01698-3
- By:
- Publication type:
- Article